BGI

B Group Inc Portfolio holdings

AUM $116M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$116M
AUM Growth
+$698K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$2.27M
2
+$1.26M
3
+$673K
4
AURA icon
Aura Biosciences
AURA
+$626K
5
SGHT icon
Sight Sciences
SGHT
+$398K

Top Sells

1
+$10.8M
2
+$1.37M
3
+$695K
4
AKRO icon
Akero Therapeutics
AKRO
+$536K
5
ASMB icon
Assembly Biosciences
ASMB
+$193K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
1
ADMA Biologics
ADMA
$3.43B
$42.2M 32.48%
2,317,542
INSM icon
2
Insmed
INSM
$35B
$15.6M 12.01%
155,000
-107,500
ZLAB icon
3
Zai Lab
ZLAB
$3.15B
$14M 10.77%
400,000
AKRO icon
4
Akero Therapeutics
AKRO
$4.32B
$12.4M 9.55%
232,446
-10,054
CLLS
5
Cellectis
CLLS
$399M
$4.97M 3.82%
3,256,501
TSHA icon
6
Taysha Gene Therapies
TSHA
$1.29B
$4.16M 3.2%
1,800,556
+545,000
RARE icon
7
Ultragenyx Pharmaceutical
RARE
$3.14B
$4M 3.08%
110,000
+62,500
SGHT icon
8
Sight Sciences
SGHT
$246M
$3.84M 2.96%
930,000
+96,400
AURA icon
9
Aura Biosciences
AURA
$352M
$3.58M 2.76%
572,576
+100,000
ASMB icon
10
Assembly Biosciences
ASMB
$226M
$3.43M 2.64%
189,350
-10,650
IOVA icon
11
Iovance Biotherapeutics
IOVA
$789M
$2.58M 1.99%
1,500,000
APGE icon
12
Apogee Therapeutics
APGE
$3.73B
$1.52M 1.17%
35,000
+5,000
PRAX icon
13
Praxis Precision Medicines
PRAX
$4B
$1.47M 1.13%
35,000
+16,000
SYRE icon
14
Spyre Therapeutics
SYRE
$1.74B
$1.2M 0.92%
80,000
+10,000
ORKA
15
Oruka Therapeutics
ORKA
$1.33B
$841K 0.65%
75,000
+16,785
BNTX icon
16
BioNTech
BNTX
$25.3B
– –
-15,000
CRVS icon
17
Corvus Pharmaceuticals
CRVS
$525M
– –
0
ETNB icon
18
89bio
ETNB
$2.19B
– –
-95,623
LLY icon
19
Eli Lilly
LLY
$720B
– –
0